CA
NZ
UK
AU
IND
US
Organogenesis is a regenerative-medicine company focused on advanced wound care and surgical and sports medicine, with a portfolio that has long included skin-substitute and tissue products such as Apligraf and Dermagraft. In the second quarter of 2026, the company reported revenue of $42.8 million, …
BeyondSpring is a clinical-stage biopharmaceutical company developing plinabulin, a selective immunomodulating microtubule-binding agent, for cancer treatment. In 2026 the company reported notable clinical signals: Phase 2 data presented at ASCO showed a 58% two-year overall survival rate in metastatic non-small cell lung cancer patients …
Anavex is a clinical-stage biotechnology company listed on theNasdaqunder AVXL, developing oral small-molecule therapies for central-nervous-system disorders. Its lead candidate, blarcamesine (ANAVEX2-73), a sigma-1 receptor agonist, is being advanced for early Alzheimer's disease, with additional programs in Rett syndrome and Fragile X syndrome.
Akebia Therapeutics is a biopharmaceutical company focused on kidney disease, listed on theNasdaqunder AKBA. Its commercial portfolio is anchored by Vafseo (vadadustat), an oral HIF-PH inhibitor for anemia due to chronic kidney disease in adults on dialysis, alongside Auryxia, an established phosphate-binder product now …
Upstream Bio is developing verekitug, a monoclonal antibody that blocks the receptor for thymic stromal lymphopoietin (TSLP), an upstream driver of inflammation implicated across respiratory disease. On September 1, 2026, the company announced pivotal Phase 3 development plans for verekitug in both severe asthma …
America Great Health describes itself as a biotechnology company focused on theResearch and Developmentof protein and peptide small-molecule drugs, alongside interests spanning AI-based diagnostic devices, cell therapy and regenerative medicine. The company is based in Alhambra, California, and was formerly known as Crown Marketing …
Nascent Biotech is a clinical-stage biopharmaceutical company developing Pritumumab, a natural human monoclonal antibody. The company has positioned Pritumumab as a treatment candidate for brain cancers such as glioblastoma, as well as epithelial cancers including lung, breast, colon and pancreatic tumors. Its most recent …
Acura is a drug-delivery company built around abuse-deterrent pharmaceutical technologies, including its Aversion and LIMITx platforms designed to reduce the potential for misuse of oral medications. Its portfolio has included Oxaydo, an immediate-release oxycodone product, and the Nexafed line of pseudoephedrine-based cold and allergy …
MoonLake is a clinical-stage biopharmaceutical company developing sonelokimab, a Nanobody designed to inhibit IL-17A and IL-17F, cytokines central to inflammatory disease. On August 10, 2026, the company announced positive topline results from its Phase 3 IZAR-1 trial of sonelokimab in psoriatic arthritis (PsA), reporting …
Yubo International Biotech is a China-focused health and personal-care company built around endometrial stem-cell research, development and application. It markets consumer and wellness products under the VIVCELL brand, spanning respiratory, skincare, hair-care and beverage lines, and offers stem-cell testing and health-management consulting services. The …
Please wait processing your request...